With its broad base of expertise, the mission of the Georgia Center for Diabetes Translation Research (GCDTR) is to facilitate and grow Type 2 translation research in diabetes within the state of Georgia. Type 2 translation is defined as research focused on translating approaches that have clearly demonstrated efficacy into real world health care settings, and communities, at risk with an emphasis on reach, sustainability, and widespread implementation.
Deadline for Next Round of GCDTR Pilot Funding is May 31
Georgia Center for Diabetes Translation Research (GCDTR) is accepting proposals for funding proposals that focus on T2 translation research in diabetes care and prevention. T2 translation is defined as research focused on translating and/or implement of interventions and approaches that have clearly demonstrated efficacy into real world health care setting, communities, and popluations at risk with an emphasis on reach and sustainability. Investigators are encouraged to propos studies that align with one or more of GCDTR's research cores: Engagement and Behavior Change, Disparities, and Design and Evaluation. Applications must be received by 5:00 pm on May 31, 2018. For more information and application instructions visit the P & F Program section.
GCDTR Presented With Health Connect South Best Collaboration Award
The Health Connect South (HCS) Best Collaboration Award for 2017 went to the Georgia Center for Diabetes Translation Research (GCDTR) during HCS's annual gathering. The HCS Collaboration Award recognizes organizations or individuals who have developed partnerships and collaborations that have contributed to advances in healthcare in the Southeast. GCDTR was recognized for its efforts to create an interdisciplinary collaboration, and for producing effective solutions that go above and beyond a mere partnership to create a platform, product, or opportunity addressing challenges in healthcare. HCS 2017 was attended by 500 leading innovators, executive decision makers, and next generation health leaders from around the Southeast.
Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988–2014
Ali MK, Bullard KM, Saydah S, Imperatore G, Gregg EW
There is controversy over the usefulness of prediabetes as a diagnostic label. Using data from US National Health and Nutrition Examination Surveys (NHANES) between 1988 and 2014, the authors examined the cardiovascular and renal burdens in adults with prediabetes over time and compared patterns with other glycaemic status groups.
Podcast interview with co-author, Dr. Mohammed K. Ali....
Solveig Cunningham, Shivani Patel, Gloria Beckles, Linda Geiss, et. al
This study explores how geographic distribution of diabetes in the US is associated with socioeconomic and built environment characteristics and health-relevant.
This Field Epidemiology Training Program Investigators Guide was produced by CDC in collaboration with EGDRC, and was led by Dr. Unjali Gujral at Emory.
Incidence of diabetes after a partner's diagnosis
Solveig A. Cunningham, Sara R. Adams, Julie A. Schmittdiel, Mohammed K. Ali, et al.
In a cohort study, we examined whether incidence of diabetes was different for individuals with recently diagnosed partners compared to individuals similar on other characteristics but whose partners were never diagnosed with diabetes.
This research studied the largest clinical lifestyle change program in the United States, the Veteran’s Health Administration’s MOVE! program.
A National Effort to PreventType 2 Diabetes: Participant-Level Evaluation of CDC’s National Diabetes Prevention Program
Elizabeth K. Ely, Stephanie M. Gruss, Elizabeth T. Luman, Edward W. Gregg, Mohammed K. Ali, Kunthea Nhim, Deborah B. Rolka, and Ann L. Albright
This paper assesses participant-level results from the first 4 years of implementation of the National Diabetes Prevention Program (National DPP), a national effort to prevent type 2 diabetes in those at risk through structured lifestyle change programs.
Cost-effectiveness and Budget Impact of Lifestyle Intervention for Diabetes Prevention in the Medicaid Population
Thu, April 5, 2018 | 12:00 pm - 1:00 pm | CNR 3001
Michael Laxy, PhD, MSc, MPH
Head, Working Group on Economics and Management of Diabetes
Harkness/B. Braun Fellow for Health Care Policy and Practice
HelmholtzZentrum Institute, Munich
Cardiometabolic Disease in South Asians: What Have We Learned in the U.S.?
Fri, April 27, 2018 | 12:00 pm - 1:00 pm | CNR 1000
Alka Kanaya, PhD
Associate Professor of Medicine
University of California, San Francisco
Fri, May 18, 2018 | 12:00 pm - 1:00 pm | CNR 3001
Lucie Levesque, PhD
Professor of Kinesiology and Health Studies,
Queens University, Kingston